» Articles » PMID: 20231484

Protein-assisted Self-assembly of Multifunctional Nanoparticles

Overview
Specialty Science
Date 2010 Mar 17
PMID 20231484
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

A bioengineering method for self-assembly of multifunctional superstructures with in-advance programmable properties has been proposed. The method employs two unique proteins, barnase and barstar, to rapidly join the structural components together directly in water solutions. The properties of the superstructures can be designed on demand by linking different agents of various sizes and chemical nature, designated for specific goals. As a proof of concept, colloidally stable trifunctional structures have been assembled by binding together magnetic particles, quantum dots, and antibodies using barnase and barstar. The assembly has demonstrated that the bonds between these proteins are strong enough to hold macroscopic (5 nm-3 microm) particles together. Specific interaction of such superstructures with cancer cells resulted in fluorescent labeling of the cells and their responsiveness to magnetic field. The method can be used to join inorganic moieties, organic particles, and single biomolecules for synergistic use in different applications such as biosensors, photonics, and nanomedicine.

Citing Articles

Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells.

Rosenkranz A, Slastnikova T Pharmaceutics. 2023; 15(3).

PMID: 36986848 PMC: 10055131. DOI: 10.3390/pharmaceutics15030987.


Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy.

Shipunova V, Komedchikova E, Kotelnikova P, Nikitin M, Deyev S Pharmaceutics. 2023; 15(3).

PMID: 36986694 PMC: 10053351. DOI: 10.3390/pharmaceutics15030833.


Biocatalytic synthesis and ordered self-assembly of silica nanoparticles via a silica-binding peptide.

Gungormus M Beilstein J Nanotechnol. 2023; 14:280-290.

PMID: 36895442 PMC: 9989680. DOI: 10.3762/bjnano.14.25.


Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo.

Obozina A, Komedchikova E, Kolesnikova O, Iureva A, Kovalenko V, Zavalko F Pharmaceutics. 2023; 15(1).

PMID: 36678860 PMC: 9861179. DOI: 10.3390/pharmaceutics15010231.


Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells.

Komedchikova E, Kolesnikova O, Tereshina E, Kotelnikova P, Sogomonyan A, Stepanov A Pharmaceutics. 2023; 15(1).

PMID: 36678681 PMC: 9861000. DOI: 10.3390/pharmaceutics15010052.


References
1.
Yarden Y, Sliwkowski M . Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001; 2(2):127-37. DOI: 10.1038/35052073. View

2.
Frey N, Peng S, Cheng K, Sun S . Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev. 2009; 38(9):2532-42. PMC: 2740941. DOI: 10.1039/b815548h. View

3.
Hartley R . Barnase-barstar interaction. Methods Enzymol. 2001; 341:599-611. DOI: 10.1016/s0076-6879(01)41179-7. View

4.
Deyev S, Waibel R, Lebedenko E, Schubiger A, Pluckthun A . Design of multivalent complexes using the barnase*barstar module. Nat Biotechnol. 2003; 21(12):1486-92. DOI: 10.1038/nbt916. View

5.
Slamon D, Godolphin W, Jones L, Holt J, Wong S, Keith D . Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989; 244(4905):707-12. DOI: 10.1126/science.2470152. View